Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PNT

POINT Biopharma Global (PNT) Stock Price, News & Analysis

POINT Biopharma Global logo

About POINT Biopharma Global Stock (NASDAQ:PNT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$12.45
$14.23
52-Week Range
N/A
Volume
3.29 million shs
Average Volume
1.44 million shs
Market Capitalization
$1.33 billion
P/E Ratio
13.89
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for POINT Biopharma Global and its competitors with MarketBeat's FREE daily newsletter.

PNT Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Lilly Completes Acquisition of POINT Biopharma
See More Headlines

PNT Stock Analysis - Frequently Asked Questions

POINT Biopharma Global Inc. (NASDAQ:PNT) posted its earnings results on Monday, November, 13th. The company reported ($0.23) EPS for the quarter, beating analysts' consensus estimates of ($0.30) by $0.07. The firm had revenue of $2.79 million for the quarter, compared to the consensus estimate of $8 million. POINT Biopharma Global had a net margin of 39.62% and a trailing twelve-month return on equity of 21.10%.

Based on aggregate information from My MarketBeat watchlists, some other companies that POINT Biopharma Global investors own include NVIDIA (NVDA), Broadcom (AVGO), Novo Nordisk A/S (NVO), Disc Medicine (IRON), Arista Networks (ANET), e.l.f. Beauty (ELF) and Builders FirstSource (BLDR).

Company Calendar

Last Earnings
11/13/2023
Today
7/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PNT
CIK
1811764
Fax
N/A
Employees
129
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.90
Trailing P/E Ratio
13.89
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$98.29 million
Net Margins
39.62%
Pretax Margin
52.16%
Return on Equity
21.10%
Return on Assets
18.28%

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
9.14
Quick Ratio
9.14

Sales & Book Value

Annual Sales
$226.58 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
13.31
Book Value
$4.68 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
106,570,000
Free Float
89,518,000
Market Cap
$1.33 billion
Optionable
Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:PNT) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners